LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 6.290
- -0.150-2.33%
Close Dec 27 16:00 ET
- 5.980
- -0.310-4.93%
Post 20:01 ET
928.27MMarket Cap-4.69P/E (TTM)
6.520High6.190Low735.64KVolume6.490Open6.440Pre Close4.64MTurnover0.84%Turnover RatioLossP/E (Static)147.58MShares7.06752wk High4.15P/B553.37MFloat Cap2.28052wk Low--Dividend TTM87.98MShs Float71.250Historical High--Div YieldTTM5.12%Amplitude2.280Historical Low6.307Avg Price1Lot Size
About Adaptive Biotechnologies Company
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Company Profile
SymbolADPT
Company NameAdaptive Biotechnologies
Listing DateJun 27, 2019
Issue Price20.00
Founded2009
CEOMr. Chad M. Robins
MarketNASDAQ
Employees709
Fiscal Year Ends12-31
Address1165 Eastlake Avenue East
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98109
Phone1-206-659-0067
Company Executives
- Name
- Position
- Salary
- Chad M. Robins
- Chairman of the Board and Chief Executive Officer
- 8.90M
- Susan Bobulsky
- Chief Commercial Officer, Minimal Residual Disease
- --
- Dr. Harlan Robins, PhD
- Chief Scientific Officer
- 8.61M
- Francis Lo
- Chief People Officer
- --
- Kyle Piskel
- Chief Financial Officer and Principal Accounting Officer
- --
- Julie Rubinstein
- President and Chief Operating Officer
- 2.97M
- Dr. Sharon Benzeno, PhD
- Chief Commercial Officer, Immune Medicine
- 2.88M
- Stacy L. Taylor
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Peter M. Neupert
- Lead Independent Director
- 355.00K
- Michelle Griffin
- Independent Director
- 330.00K
- Dr. Robert M. Hershberg, M.D.,PhD
- Independent Director
- 325.00K
- Katey Einterz Owen
- Independent Director
- 310.00K
- Dr. Michael J. Pellini,M.D.
- Independent Director
- 310.00K